Variability of dynamic contrast-enhanced MRI in the pituitary adenoma: Prospective comparison between gadobutrol and meglumine gadoterate usage
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0006668
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Adults who are planned to undergo pituitary MRI including DCE-MRI for the suspicion of the pituitary tumor and agree to be included in this prospective study
Exclusion Criteria
-
Under age 19 years old, pregant woman, those who do not agree to be included in this study, those who have history of side effect for the gadolinium-based MRI contrast agent including allergic reaction, those who have severe kidney or heart problem, those who have intractable hypokalemia, those who cannot be injected with gadolinium-based MRI contrast-agent from various reasons
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method volume transfer (Ktrans, Kep), extracellular space volume (Ve), plasma volume (Vp), and area-under-the-curve (AUC)
- Secondary Outcome Measures
Name Time Method diagnostic performance for the pituitary adenoma